Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

October 22, 2008 10:00 ET | Source: MediciNova, Inc.

MediciNova to Present At the 7th Annual BIO Investor Forum

SAN DIEGO, Oct. 22, 2008 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company that is publicly traded on the Nasdaq Global Market (Nasdaq:MNOV) and the Hercules Market of the Osaka...
September 18, 2008 18:00 ET | Source: MediciNova, Inc.

Data From MediciNova's Two-Year Phase II Clinical Trial of MN-166 in Multiple Sclerosis Presented At the World Congress for Treatment and Research in MS (WCTRIMS)

SAN DIEGO, Sept. 18, 2008 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company that is publicly traded on the Nasdaq Global Market (Nasdaq:MNOV) and the Hercules Market of the Osaka...
September 09, 2008 06:00 ET | Source: MediciNova, Inc.

MediciNova Reports Positive Preliminary Results from Phase II Clinical Trial of MN-221 in Moderate to Severe Asthma Patients

SAN DIEGO, Sept. 9, 2008 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company that is publicly traded on the Nasdaq Global Market (Nasdaq:MNOV) and the Hercules Market of the Osaka...
September 08, 2008 10:00 ET | Source: MediciNova, Inc.

MediciNova to Present At Merriman Curhan Ford's 5th Annual Investor Summit 2008

SAN DIEGO, Sept. 8, 2008 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company that is publicly traded on the Nasdaq Global Market (Nasdaq:MNOV) and the Hercules Market of the Osaka...
August 11, 2008 17:15 ET | Source: MediciNova, Inc.

MediciNova Reports Second Quarter 2008 Results

SAN DIEGO, Aug. 11, 2008 (PRIME NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company that is publicly traded on the Nasdaq Global Market (Nasdaq:MNOV) and the Hercules Market of the Osaka...
July 07, 2008 06:00 ET | Source: MediciNova, Inc.

MediciNova to Present At the 4th Annual Collins Stewart Growth Conference

SAN DIEGO, July 7, 2008 (PRIME NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company that is publicly traded on the Nasdaq Global Market (Nasdaq:MNOV) and the Hercules Market of the Osaka...
July 02, 2008 06:00 ET | Source: MediciNova, Inc.

MediciNova to Host Analyst/Investor Meeting in New York City

SAN DIEGO, July 2, 2008 (PRIME NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company that is publicly traded on the Nasdaq Global Market (Nasdaq:MNOV) and the Hercules Market of the Osaka...
June 23, 2008 06:00 ET | Source: MediciNova, Inc.

MediciNova Initiates Phase II Clinical Trial of MN-221 in Moderate to Severe Asthma Patients

SAN DIEGO, June 23, 2008 (PRIME NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company that is publicly traded on the Nasdaq Global Market (Nasdaq:MNOV) and the Hercules Market of the Osaka...
May 13, 2008 18:01 ET | Source: MediciNova, Inc.

MediciNova to Present At the Rodman and Renshaw 5th Annual Global Healthcare Conference

SAN DIEGO, May 13, 2008 (PRIME NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company that is publicly traded on the Nasdaq Global Market (Nasdaq:MNOV) and the Hercules Market of the Osaka...
May 12, 2008 17:37 ET | Source: MediciNova, Inc.

MediciNova Reports First Quarter 2008 Results

SAN DIEGO, May 12, 2008 (PRIME NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company that is publicly traded on the Nasdaq Global Market (Nasdaq:MNOV) and the Hercules Market of the Osaka...